title: Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia.
abstract: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is classified into three types based on disease severity: classic salt-wasting, classic simple virilizing, and nonclassic. Adrenomedullary dysplasia and epinephrine deficiency have been described in classic CAH, resulting in glucose dysregulation. Our objective was to investigate adrenomedullary function in nonclassic CAH and to evaluate adrenomedullary function according to disease severity. Adrenomedullary function was evaluated in response to a standardized cycle ergonometer test in 23 CAH patients (14 females, age 9-38 years; 6 salt-wasting, 7 simple virilizing, 5 nonclassic receiving glucocorticoid treatment, 5 nonclassic not receiving glucocorticoid), and 14 controls (7 females, age 12-38 years). Epinephrine, glucose, and cortisol were measured at baseline and peak exercise. CAH patients and controls were similar in age and anthropometric measures. Patients with nonclassic CAH who were not receiving glucocorticoid and controls experienced the expected stress-induced rise in epinephrine, glucose, and cortisol. Compared to controls, patients with all types of CAH receiving glucocorticoid had impaired exercise-induced changes in epinephrine (salt-wasting: p=0.01;simple virilizing: p=0.01; nonclassic: p=0.03), and cortisol (salt-wasting: p=0.004; simple virilizing: p=0.006; nonclassic: p=0.03). Salt-wasting patients displayed the most significant impairment, including impairment in glucose response relative to controls (p=0.03). Hydrocortisone dose was negatively correlated with epinephrine response (r=-0.58; p=0.007) and glucose response (r=-0.60; p=0.002). The present study demonstrates that untreated patients with nonclassic CAH have normal adrenomedullary function. The degree of epinephrine deficiency in patients with CAH is associated with the severity of adrenocortical dysfunction, as well as glucocorticoid therapy.
authors.affiliation: The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA. dmerke@nih.gov
authors.forename: S
authors.initials: S
authors.lastname: Verma
authors.forename: L
authors.initials: L
authors.lastname: Green-Golan
authors.forename: C
authors.initials: C
authors.lastname: VanRyzin
authors.forename: B
authors.initials: B
authors.lastname: Drinkard
authors.forename: S P
authors.initials: SP
authors.lastname: Mehta
authors.forename: M
authors.initials: M
authors.lastname: Weise
authors.forename: G
authors.initials: G
authors.lastname: Eisenhofer
authors.forename: D P
authors.initials: DP
authors.lastname: Merke
mesh_terms: D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000097:blood / Q000503:physiopathology*; D000313:Adrenal Medulla / Q000503:physiopathology*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D016022:Case-Control Studies; D002648:Child; D004837:Epinephrine / Q000097:blood; D005080:Exercise Test; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D006854:Hydrocortisone; D004837:Epinephrine
references.citation: J Clin Endocrinol Metab. 2009 May;94(5):1570-8
references.pmid: 19208730
references.citation: Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):105-10
references.pmid: 16636975
references.citation: J Clin Invest. 1992 Aug;90(2):584-95
references.pmid: 1644925
references.citation: Klin Padiatr. 1975 Jul;187(4):308-13
references.pmid: 1172155
references.citation: J Clin Endocrinol Metab. 2002 Jul;87(7):3031-7
references.pmid: 12107196
references.citation: J Clin Endocrinol Metab. 2004 Feb;89(2):591-7
references.pmid: 14764767
references.citation: J Clin Endocrinol Metab. 2004 Aug;89(8):3679-84
references.pmid: 15292287
references.citation: J Clin Endocrinol Metab. 2001 Dec;86(12):5920-4
references.pmid: 11739465
references.citation: N Engl J Med. 2000 Nov 9;343(19):1362-8
references.pmid: 11070100
references.citation: Acta Endocrinol Suppl (Copenh). 1986;279:275-8
references.pmid: 3465167
references.citation: Pediatr Res. 1973 Dec;7(12):983-93
references.pmid: 4356642
references.citation: J Clin Endocrinol Metab. 2007 Aug;92(8):3019-24
references.pmid: 17535996
references.citation: Arch Dis Child. 1994 Mar;70(3):214-8
references.pmid: 8135566
references.citation: Arch Pediatr. 1994 Sep;1(9):827-40
references.pmid: 7842128
references.citation: Horm Metab Res. 2009 Sep;41(9):710-4
references.pmid: 19551609
references.citation: Metabolism. 1983 Oct;32(10):960-70
references.pmid: 6350809
references.citation: Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1603-4
references.pmid: 6439337
references.citation: J Clin Endocrinol Metab. 1981 Jun;52(6):1106-12
references.pmid: 7014593
references.citation: Diabetes. 2009 Sep;58(9):2100-8
references.pmid: 19509020
references.citation: J Clin Endocrinol Metab. 2002 May;87(5):2114-20
references.pmid: 11994350
references.citation: Clin Chem. 1986 Nov;32(11):2030-3
references.pmid: 3096593
references.citation: Lancet. 2005 Jun 18-24;365(9477):2125-36
references.pmid: 15964450
references.citation: J Pediatr. 1990 Dec;117(6):892-6
references.pmid: 2104527
references.citation: Adv Metab Disord. 1971;5:53-76
references.pmid: 4934168
references.citation: Am J Physiol. 1991 May;260(5 Pt 1):E705-12
references.pmid: 1674642
references.citation: Ann N Y Acad Sci. 2008 Dec;1148:112-7
references.pmid: 19120098
references.citation: Horm Metab Res. 2008 Oct;40(10):668-73
references.pmid: 18553255
references.citation: Med Sci Sports Exerc. 1982;14(5):377-81
references.pmid: 7154893
references.citation: Arch Dis Child. 1977 Jul;52(7):591-3
references.pmid: 879852
references.citation: Horm Metab Res. 2008 May;40(5):347-53
references.pmid: 18491255
references.citation: J Clin Endocrinol Metab. 1972 Jun;34(6):948-58
references.pmid: 5020424
references.citation: Horm Metab Res. 1997 Jan;29(1):30-2
references.pmid: 9049651
references.citation: J Clin Endocrinol Metab. 2010 Mar;95(3):1182-90
references.pmid: 20080854